Cerity Partners LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cerity Partners LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$1,044,598
+10.4%
67,524
+12.1%
0.01%
+25.0%
Q2 2023$945,847
-73.2%
60,223
-3.3%
0.00%
-50.0%
Q1 2023$3,535,250
+312.2%
62,295
+13.3%
0.01%
+60.0%
Q4 2022$857,612
-15.2%
54,991
-29.4%
0.01%
-58.3%
Q3 2022$1,011,000
+34.4%
77,927
+45.5%
0.01%
+50.0%
Q2 2022$752,000
+63.8%
53,562
+66.4%
0.01%
+14.3%
Q1 2022$459,000
+81.4%
32,196
+72.3%
0.01%
+75.0%
Q4 2021$253,000
+11.9%
18,689
+35.6%
0.00%
-20.0%
Q3 2021$226,000
-3.0%
13,785
-0.2%
0.01%0.0%
Q2 2021$233,000
-13.1%
13,819
-6.0%
0.01%
-16.7%
Q1 2021$268,000
-48.7%
14,701
-48.7%
0.01%
-64.7%
Q4 2020$522,000
+4.6%
28,679
+2.6%
0.02%
-19.0%
Q3 2020$499,000
-0.4%
27,9540.0%0.02%
-25.0%
Q2 2020$501,000
+77.7%
27,954
+50.2%
0.03%
+55.6%
Q1 2020$282,000
-20.8%
18,608
+3.0%
0.02%0.0%
Q4 2019$356,000
+20.7%
18,062
+5.1%
0.02%
+5.9%
Q3 2019$295,000
-20.1%
17,178
-17.6%
0.02%
-26.1%
Q2 2019$369,000
-29.7%
20,837
-19.1%
0.02%
-34.3%
Q1 2019$525,00025,7660.04%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders